Learn More
Medchemexpress LLC (E)-5-(dimethylamino)-2-(pyridin-2-yldiazenyl)phenol methanesulfonate | 2756327-67-8 | 95.0% | 338.38 g·mol⁻¹ | C14H18N4O4S | 5 MG

Supplier: Medchemexpress LLC HY1398935MG
ERGi-USU-6 mesylate is the methanesulfonate salt of a small-molecule inhibitor that targets the ERG transcription factor and RIOK2 kinase. It has reported in vitro anticancer activity against ERG-positive prostate cancer cell lines and is supplied for laboratory research use only. The material is provided as a solid (brown to black) with reported purity of 95.0% and supporting documentation available.
- Inhibits ERG transcription factor and RIOK2 kinase.
- Demonstrates anticancer activity in ERG-positive prostate cancer cell lines.
- Supplied for research use only; not for human or veterinary use.
- Provided as a solid, brown to black, with 95.0% purity.
- Includes datasheet, certificate of analysis, and SDS for quality and safety information.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.